Home Low Income Tags

View the Latest: Low Income

Filter

List Grid

491 - 498 of 498 Results

  • What’s in the Administration’s 5-Part Plan for Medicare Part D and What Would it Mean for Beneficiaries and Program Savings?

    Issue Brief

    With rising concern over increases in prescription drug costs, the Trump Administration has proposed what it calls a “5-part plan” that would change several features of the Medicare Part D drug benefit. This brief describes the Administration’s five Part D proposals and discusses the potential implications for people with Part D prescription drug coverage and Medicare program spending, based on estimates from the Congressional Budget Office.

  • Texans’ Experiences with Health Care Affordability and Access

    Report

    Using data from the Kaiser Family Foundation/Episcopal Health Foundation 2018 Texas Health Policy Survey, this brief explores Texas residents’ experiences with health care affordability and access to care. It examines Texans’ difficulty affording health care compared to other basic needs, problems paying medical bills, and skipping or postponing care because of costs. It also explores the experiences of vulnerable groups like the uninsured and those with lower incomes.

  • Hurricane Harvey: The Experiences of Immigrants Living in the Texas Gulf Coast

    Report

    In order to better understand the particular needs of immigrants both in recovering from and preparing for future storms, this analysis from the Kaiser Family Foundation and the Episcopal Health Foundation highlights the views and experiences of foreign-born residents who were living in 24 coastal Texas counties hard-hit by Hurricane Harvey. Specifically, the brief explores the financial circumstances of immigrants following the storm, as well as their health care access, social support, and top priorities…

  • How is the ACA Impacting Medicaid Enrollment?

    Issue Brief

    This issue brief provides an overview of new Medicaid enrollment data released by Centers for Medicare and Medicaid Services and its interpretation to assess the influence of the ACA on Medicaid enrollment.

  • The Implications of COVID-19 for Mental Health and Substance Use

    Issue Brief

    This brief explores mental health and substance use during, and prior to, the COVID-19 pandemic. We highlight populations that were more likely to experience worse mental health and substance use outcomes during the pandemic and discuss some innovations in the delivery of services.

  • Medicare Part D in Its Ninth Year: The 2014 Marketplace and Key Trends, 2006-2014

    Report

    This report presents findings from an analysis of the Medicare Part D marketplace in 2014 and changes in features of the drug benefit offered by Part D plans since 2006. It examines the latest information and trends related to Part D enrollment and plan availability, premiums, benefit design and cost sharing, pharmacy networks, the Low-Income Subsidy Program, and plan performance ratings.

  • Options to Make Medicare More Affordable For Beneficiaries Amid the COVID-19 Pandemic and Beyond

    Report

    Medicare provides significant health and financial protections to more than 60 million Americans, but there are gaps in coverage and high cost-sharing requirements that can make health care difficult to afford. This report analyzes several policy options that could help make health care more affordable for people covered by Medicare, especially beneficiaries with relatively low incomes: adding an out-of-pocket limit to traditional Medicare, adding a hard out-of-pocket cap to Part D, expanding financial assistance through…

  • Who Didn’t Get a Second Shingrix Shot? Implications for Multidose COVID-19 Vaccines

    Issue Brief

    As the U.S. prepares for nationwide distribution of vaccines to combat COVID-19, some are asking whether people who get the first of two doses will return to complete the series. This analysis draws on Medicare Part D prescription drug claims data for the herpes zoster vaccine Shingrix, which also requires two doses, to shed light on this potential challenge of the leading COVID-19 vaccine candidates.